Clinical Trials Browser

Phase 1/2 × Chromosome 17 deletion × dexamethasone 21-phosphate × Clear all

NCT02633059 2024-09-19

Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Phase 1/2 Completed

33 enrolled 26 charts

Chromosome 17 deletion, Multiple Myeloma